Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Catheter-Related Infections' returned 32 results - Page 1 of 2   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Catheter-Related Infections, Second Edition   Informa Healthcare, Dec 2004, Pages: 648 Catheter-Related Infections, Second Edition This updated reference describes the latest and most effective strategies in the diagnosis, management, and treatment of catheter-related infections (CRIs Hospital-Acquired Infection Incidence - Trends in Australia   Frost & Sullivan, May 2011, Pages: 93 Infections: Number of Hospitals (Australia), 2009 - Blood Stream Infections: Predominant Pathogens Causing BSI (World), 2006-2009 - Blood Stream Infections: Percent of Catheter-related BSI by Pathogen Urological Catheters - Global Strategic Business Report   Global Industry Analysts, Inc., Aug 2011, Pages: 498 41 Treatment and Remedial Measures for Catheter-Related Infections 42 Fight Against Infection 43 Other Complications Competitor Analysis: Anti-Infective Peptides   La Merie Publishing, Dec 2011, Pages: 44 gram- infections, prevention of catheter-related infections, otitis media, gingivitis and many more. Anti-Fungal Peptides: Anti-fungal peptides are used to treat infections such as oesophageal U.S. Market for Vascular Access Devices and Accessories 2010   iData Research, Feb 2010, Pages: 336 the number of vascular access-related infections caused while receiving medical care. Within the vascular access device market, companies such as Baxter, Becton Dickinson, CareFusion, CR. Bard and Cardiovascular Catheters and Systems - Global Strategic Business Report   Global Industry Analysts, Inc., April 2008, Pages: 568 Competitiveness II-10 Preventing Infection II-10 Catheter Related Infections II-10 Drug and Device Combination (2009 - 2014)   Markets and Markets, July 2009, Pages: 222 . Oximetry Catheters 4.1.6.1. Drivers 4.1.6.1.1. Reduction In Catheter Related Blood Stream Infections 4.1.6.1.2. Prolonged Fight Against Micro Organisms 4.1.6.1.3. Overall Cost Of Hospitalization Will U.S. Medical Catheter Markets   Frost & Sullivan, Dec 2005 by eliminating the risk of restenosis or catheter-related infections. Coating technology improvements are expected to increase the total number of medical procedures involving catheters, especially Central Venous Catheters - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017   GlobalData, Jan 2012, Pages: 63 Infections, Global Table 5: Catheter Related Bloodstream Infections by Country Table 6: Central Venous Catheters Market, The US, Revenue ($m), 2003-2010 Table 7: Central Venous Catheters Market, The US Emerging Medical Technologies Spotlight, A Report Of Investment & Partnering Opportunities, 2011   Life Science Intelligence, Inc., Dec 2011, Pages: 605 device for the prevention of catheter-related infections from hemodialysis - Diagnostic tests that leverage the ability to extract clinically relevant information from maternal blood, including a non Emerging Medical Technologies Spotlight, a Report of Investment & Partnering Opportunities 2010   Life Science Intelligence, Inc., Jan 2011 healthcare device for use by patients to self-measure Intraocular Pressure (IOP) - Miniature/patient-controllable/valved catheter to improve quality of life/decrease urinary tract infections in patients U.S. Market for Vascular Access Devices and Accessories 2010 (Executive Summary)   iData Research, Feb 2010, Pages: 336 reimbursement changes that aim to reduce the number of vascular access-related infections caused while receiving medical care. Within the vascular access device market, companies such as Baxter, Becton Emerging Medical Technologies Spotlight, a Report of Investment & Partnering Opportunities 2009   Life Science Intelligence, Inc., Dec 2009, Pages: 1763 - Diagnostic and therapeutic catheter-based devices for prevention/treatment of heart attacks caused by soft plaque - Electrical stimulators via electrode garments for the treatment of pain related to chronic Kidney Dialysis Equipment and Supplies - Global Strategic Business Report   Global Industry Analysts, Inc., Sep 2010, Pages: 564 41 Catheter-Related Complications of PD Technique 41 8. PRODUCT INNOVATIONS/INTRODUCTIONS 43 AngioDynamics Introduces Gene Therapy - Technologies, Markets and Companies   Jain PharmaBiotech, May 2012, Pages: 658 , cardiovascular diseases, neurological disorders and viral infections with emphasis on AIDS. Applications of gene therapy in veterinary medicine, particularly for treating cats and dogs, are included. Research and Urinary Tract Infections: Growing Resistance Rates bring Opportunities for Both New and Old Drugs   Datamonitor, April 2009, Pages: 126 Scope of the analysis Insight into the urinary tract infections market Contributing experts Related reports Upcoming related reports CHAPTER 2 EPIDEMIOLOGY AND DISEASE BACKGROUND Etiology and symptoms Emerging Medical Technologies (EMT) Database   Life Science Intelligence, Inc., July 2007 technology for Contrast Ultrasound imaging Company 237 - Miniature/patient-controllable/valved catheter to improve quality of life/decrease urinary tract infections in patients suffering urinary retention Infection Control in Ambulatory Care (2012 update)   Apollo Managed Care Consultants, Jan 2012, Pages: 126 Plan Creutzfeldt-Jackob Disease (CJD)/v CJD with other Transmissible Spongiform Encelphalopathies Skin Disinfection to Prevent Catheter-related Blood-stream Infection Screening for Methicillin Cell Therapy - Technologies, Markets and Companies   Jain PharmaBiotech, May 2012, Pages: 1015 Advantages of UCB Limitations of the use of UCB Licensing and patent disputes involving UCB Infections following UCB transplants Unanswered questions about UCB transplantation Companies involved in UCB Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies   Jain PharmaBiotech, May 2012, Pages: 345 Cerebrovascular disease Epilepsy Infections Mitochondrial encephalopathies Multiple sclerosis Neurodegenerative disorders Testing permeability of the BBB In vitro models of BBB In vivo study of BBB Brain Results:  First -   Prev -   1 -   2 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets1    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network